Studies have shown that human bone marrow-derived MSC-exos (BMSC-exos) can deliver miR-425 into lung cancer cells, inhibit CPEB1 expression, and promote lung cancer cell proliferation, invasion, and metastasis [75]. Here, CPEB1 is linked to lung cancer.